Unlike a landmass, technological advantage is not fixed. It must be cultivated, protected, and renewed constantly, argues .

RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in ...

(Nasdaq: EXEL) today reported financial results for the second quarter of 2025, provided an update on progress toward achieving key corporate objectives, and outlined its commercial, clinical and ...

Sarah Wood, research chair in pollinator health at University of Saskatchewan, has looked at how FASD affects the movements ...

From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ ...